Immunowake, Inc.

Immunowake, Inc. is a biotechnology company based in Birmingham, Alabama, specializing in cancer drug discovery. We are dedicated to developing safe and effective cytokine immune modulators, aiming to overcome tumor immune suppression and reactivate the patient’s own immune system to identify and eliminate cancer cells. Our approach, reflected in our name ‘Immunowake,’ focuses on ‘awakening’ the immune system to offer renewed hope. We leverage a robust research platform and a strong research pipeline to treat both cancer and autoimmune diseases.

Our core technology centers on precisely delivering cytokines to maximize their anti-tumor potential while minimizing systemic toxicity. This innovative strategy utilizes cytokines – key players in coordinating immune cell activation – to effectively combat cancer.

Immunowake is building a powerful pipeline of immune cytokine therapies, and recently secured investment from Haiju Talent Investment Fund, further solidifying our position at the forefront of cancer immunotherapy.